What if fat loss could be achieved without impacting metabolism? Recorded live at AIS 2025, Dr. Grant Stevens speaks with Alon Bloomenfeld, Executive Chair of Raziel Therapeutics, about a new class of injectable fat reduction—one that works locally, not systemically.
Unlike semaglutide or other metabolic treatments, this lipophilic compound directly destroys fat cells at the site of injection, offering a highly targeted, non-surgical solution for body contouring. With FDA Phase III trials underway, Bloomenfeld shares what sets this breakthrough apart.

» Apple Podcasts | https://podcasts.apple.com/us/podcast/technology-of-beauty/id1510898426
» Spotify | https://open.spotify.com/show/0hEIiwccpZUUHuMhlyCOAm
» Recent episodes | https://www.influxmarketing.com/technology-of-beauty/
» Instagram | https://www.instagram.com/thetechnologyofbeauty/
» LinkedIn | https://www.linkedin.com/company/the-technology-of-beauty/
The Technology of Beauty is produced by Influx Marketing, The Digital Agency for Aesthetic Practices. https://www.influxmarketing.com/
Want more aesthetic insights? Subscribe to Next Level Practices, the show where we discuss the ever-changing world of digital marketing and patient acquisition and bring you the latest ideas, strategies, and tactics to help you take your practice to the next level. https://www.influxmarketing.com/next-level-practices/